该产品被引用文献
1, Lombana, TN; et al. High-resolution glycosylation site-engineering method identifies MICA epitope critical for shedding inhibition activity of anti-MICA antibodies. MAbs, Pubmed: 30307368
2, Ramos, J; et al. Hydrodynamic and electrophoretic properties of Trastuzumab/HER2 complexes. Experiments and modeling.. bioRxiv
3, Conilh, L; et al. Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform. Pharmaceuticals
4, Chabrol, E; et al. Biochemistry, structure, and cellular internalization of a four nanobody-bearing Fc dimer. Protein science : a publication of the Protein Society, Pubmed: 34117809
5, Matić, I; et al. White blood cell subsets in HER2-positive breast cancer patients treated with trastuzumab in relation to clinical outcome. Pathology - Research and Practice
6, Huo, Y; et al. M1 polarization enhances the antitumor activity of chimeric antigen receptor macrophages in solid tumors. Journal of translational medicine, Pubmed: 36978075
7, Mattsson, J; et al. Sequence enrichment profiles enable target-agnostic antibody generation for a broad range of antigens. Cell Reports Methods
8, Pekar, L; et al. Biophysical and biochemical characterization of a VHH-based IgG-like bi- and trispecific antibody platform. mAbs
9, Li, J; et al. Single-step Enzymatic Glycoengineering for the Construction of Antibody-cell Conjugates. bioRxiv
10, Huang, S; et al. Structural and functional characterization of MBS301, an afucosylated bispecific anti-HER2 antibody. MAbs, Pubmed: 30081724
11, Vega, JF; et al. Molecular and hydrodynamic properties of human epidermal growth factor receptor HER2 extracellular domain and its homodimer: Experiments and multi-scale simulations. Biochim. Biophys. Acta, Pubmed: 28642126
12, Aubé, A; et al. Ultra-low fouling methylimidazolium modified surfaces for the detection of HER2 in breast cancer cell lysates. Analyst, Pubmed: 28560368
13, Eletxigerra, U; et al. Surface plasmon resonance immunosensor for ErbB2 breast cancer biomarker determination in human serum and raw cancer cell lysates. Anal. Chim. Acta, Pubmed: 26755150
14, Nilvebrant, J; et al. Engineering of Bispecific Affinity Proteins with High Affinity for ERBB2 and Adaptable Binding to Albumin. PLoS ONE, Pubmed: 25089830
15, Gilabert-Oriol, R; et al. Modified trastuzumab and cetuximab mediate efficient toxin delivery while retaining antibody-dependent cell-mediated cytotoxicity in target cells. Mol. Pharm., Pubmed: 24050452
16, Markiv, A; et al. Expression of recombinant multi-coloured fluorescent antibodies in gor -/trxB- E. coli cytoplasm. BMC Biotechnol., Pubmed: 22129156
17, Ramos, J; et al. Hydrodynamic and Electrophoretic Properties of Trastuzumab/HER2 Extracellular Domain Complexes as Revealed by Experimental Techniques and Computational Simulations. Int J Mol Sci, Pubmed: 30832287
18, Chabrol, E; et al. VHH characterization.Recombinant VHHs: Production, characterization and affinity. Analytical Biochemistry
19, Bansal, R; et al. Elucidating the Binding Mechanism of a Novel Silica-Binding Peptide. Biomolecules
20, Bansal, R; et al. The Effect of Oligomerization on A Solid-Binding Peptide Binding to Silica-Based Materials. Nanomaterials (Basel), Pubmed: 32486317
21, AE Albers; et al. Exploring the effects of linker composition on site-specifically modified antibody-drug conjugates. European Journal of Medicinal Chemistry, Pubmed: 25176286
22, Murakami, S; Matsumoto, R; Kanamori, T. Constructive approach for synthesis of a functional IgG using a reconstituted cell-free protein synthesis system. Sci Rep, Pubmed: 30679500
23, Park, HJ; Kim, Y; Yoo, TH. One-pot colorimetric detection of molecules based on proximity proteolysis reaction. Biosensors & bioelectronics, Pubmed: 34030090
24, Westerberg, C. Development of an Affibody-based Prodrug Against HER2 for Cancer Therapy. Thesis
25, Yu, F; Alesand, V; Nygren, PÅ. Site-Specific Photoconjugation of Beta-Lactamase Fragments to Monoclonal Antibodies Enables Sensitive Analyte Detection via Split-Enzyme Complementation. Biotechnol J, Pubmed: 29485240
26, Henanger, KJ. Development of an immunoassay for human epidermal growth factor receptor 2 (HER2). Thesis
27, Kim, J; Suh, JS; Yang, J. Labeling-free detection of ECD-HER2 protein using aptamer-based nano-plasmonic sensor. Nanotechnology, Pubmed: 31914433